Jun 3, 2026 08:31AM
Jun 3, 2026 08:30AM
May 26, 2026 04:01PM
May 21, 2026 04:37PM
May 18, 2026 04:06PM
May 18, 2026 04:05PM
May 18, 2026 08:47AM Neurocrine completes $2.9 billion acquisition of Soleno Therapeutics
May 18, 2026 08:46AM
May 6, 2026 08:32AM
May 6, 2026 08:30AM
May 5, 2026 04:01PM
May 5, 2026 09:00AM
May 4, 2026 08:30AM
May 4, 2026 07:30AM Neurocrine begins phase 1 trial of obesity drug targeting new mechanism
May 4, 2026 07:30AM
May 1, 2026 04:06PM
May 1, 2026 04:05PM
Apr 29, 2026 04:07PM
Apr 29, 2026 04:05PM
Apr 22, 2026 04:05PM
Apr 22, 2026 04:05PM Neurocrine Biosciences Presents New Two-Year CRENESSITY® (crinecerfont) Data Showing Sustained Glucocorticoid Dose Reductions While Maintaining Androgen Control in Adults with Classic Congenital Adre
Apr 14, 2026 04:01PM
Apr 14, 2026 08:32AM
Apr 14, 2026 08:30AM
Apr 8, 2026 07:13AM
Apr 6, 2026 01:59PM
Apr 6, 2026 07:01AM
Apr 6, 2026 07:00AM Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
Mar 26, 2026 08:33AM
Mar 26, 2026 08:30AM
Mar 17, 2026 04:09PM
Mar 17, 2026 04:05PM
Mar 10, 2026 04:01PM
Feb 24, 2026 04:01PM
Feb 11, 2026 04:01PM Neurocrine Biosciences Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Financial Expectations for 2026
Jan 26, 2026 08:30AM
Jan 26, 2026 08:30AM
Jan 21, 2026 04:01PM
Jan 15, 2026 08:32AM
Jan 15, 2026 08:30AM
Jan 5, 2026 04:01PM
Dec 22, 2025 04:05PM Neurocrine KINECT study fails to meet primary endpoints for cerebral palsy
Dec 22, 2025 04:05PM
Dec 21, 2025 08:00PM
Dec 16, 2025 04:01PM
Dec 9, 2025 04:01PM
Nov 20, 2025 08:30AM
Nov 20, 2025 08:30AM
Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers
Nov 11, 2025 04:01PM

322,218 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All